JP2002514054A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514054A5
JP2002514054A5 JP1998515028A JP51502898A JP2002514054A5 JP 2002514054 A5 JP2002514054 A5 JP 2002514054A5 JP 1998515028 A JP1998515028 A JP 1998515028A JP 51502898 A JP51502898 A JP 51502898A JP 2002514054 A5 JP2002514054 A5 JP 2002514054A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998515028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514054A (ja
Filing date
Publication date
Priority claimed from US08/716,926 external-priority patent/US6025192A/en
Priority claimed from US08/820,931 external-priority patent/US6255071B1/en
Application filed filed Critical
Publication of JP2002514054A publication Critical patent/JP2002514054A/ja
Publication of JP2002514054A5 publication Critical patent/JP2002514054A5/ja
Ceased legal-status Critical Current

Links

JP51502898A 1996-09-20 1997-09-22 ウイルスベクターおよびそれらの使用 Ceased JP2002514054A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/716,926 1996-09-20
US08/716,926 US6025192A (en) 1996-09-20 1996-09-20 Modified retroviral vectors
US08/820,931 US6255071B1 (en) 1996-09-20 1997-03-19 Mammalian viral vectors and their uses
US08/820,931 1997-03-19
PCT/US1997/017579 WO1998012339A2 (en) 1996-09-20 1997-09-22 Viral vectors and their uses

Publications (2)

Publication Number Publication Date
JP2002514054A JP2002514054A (ja) 2002-05-14
JP2002514054A5 true JP2002514054A5 (enExample) 2005-05-12

Family

ID=27109627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51502898A Ceased JP2002514054A (ja) 1996-09-20 1997-09-22 ウイルスベクターおよびそれらの使用

Country Status (6)

Country Link
US (1) US6255071B1 (enExample)
EP (1) EP0932695A2 (enExample)
JP (1) JP2002514054A (enExample)
AU (1) AU738156B2 (enExample)
IL (1) IL128882A (enExample)
WO (1) WO1998012339A2 (enExample)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1053317B1 (en) 1998-02-13 2006-11-02 Köster, Hubert Use of ribozymes for functionating genes
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
DE19956568A1 (de) * 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US20010046669A1 (en) * 1999-02-24 2001-11-29 Mccobmie William R. Genetically filtered shotgun sequencing of complex eukaryotic genomes
US6342356B1 (en) 1999-03-12 2002-01-29 Gpc Biotech, Inc. Methods and regents for identifying synthetic genetic elements
AU3893000A (en) * 1999-03-16 2000-10-04 Dana-Farber Cancer Institute, Inc. Lentiviral vector system for high quantity screening
WO2000066758A1 (en) * 1999-04-29 2000-11-09 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
US20050266544A1 (en) * 1999-04-30 2005-12-01 Human Gene Therapy Research Institute Methods and compositions for increasing viral vector production in packaging cell lines
US7829693B2 (en) * 1999-11-24 2010-11-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
US20030084471A1 (en) 2000-03-16 2003-05-01 David Beach Methods and compositions for RNA interference
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
AU2001270252B2 (en) * 2000-07-03 2007-02-08 Catalent Pharma Solutions, Llc Expression vectors
AU2001271614B2 (en) * 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
US20040235173A1 (en) * 2000-07-03 2004-11-25 Gala Design, Inc. Production of host cells containing multiple integrating vectors by serial transduction
US20030175972A1 (en) * 2000-10-20 2003-09-18 Daley George Q. Expression vectors and uses thereof
AU1536302A (en) * 2000-10-25 2002-05-06 Monsanto Technology Llc Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
AU2002246829A1 (en) * 2000-12-22 2002-07-30 The Government Of The United States Of America, Represented By The Secretary, Department Of Health A Methods to control the host range of retroviral vectors
US8546143B2 (en) 2001-01-09 2013-10-01 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
CA2437309A1 (en) * 2001-02-05 2002-08-15 Minos Biosystems Limited Insertional mutagenesis technique
US20030082140A1 (en) * 2001-08-20 2003-05-01 Fisher Paul B. Combinatorial methods for inducing cancer cell death
US20030054354A1 (en) * 2001-08-23 2003-03-20 Bennett C. Frank Use of antisense oligonucleotide libraries for identifying gene function
US20030050266A1 (en) * 2001-09-07 2003-03-13 Fisher Paul B. Anti-tumor effects of prostate carcinoma tumor antigen-1
US7737124B2 (en) * 2001-09-13 2010-06-15 California Institute Of Technology Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
EP1424895B1 (en) * 2001-09-13 2009-08-12 California Institute Of Technology Method for expression of small antiviral rna molecules within a cell
US7195916B2 (en) * 2001-09-13 2007-03-27 California Institute Of Technology Method for expression of small antiviral RNA molecules within a cell
US7384738B2 (en) * 2002-03-28 2008-06-10 Bremel Robert D Retrovirus-based genomic screening
US20040038304A1 (en) * 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
EP1912069A3 (en) 2002-06-05 2008-07-09 Sopherion Therapeutics, Inc. Method to screen ligands using eukaryotic cell display
WO2003104415A2 (en) * 2002-06-05 2003-12-18 Sopherion Therapeutics, Inc. Method to screen ligands using eukaryotic cell display
PT1534819E (pt) 2002-08-21 2010-03-11 Revivicor Inc Animais porcinos carecendo de qualquer expressão de alfa 1,3-galactosiltransferase funcional
US20040052161A1 (en) * 2002-09-17 2004-03-18 Steven Liao Mechanical clock having wireless manipulation and adjustment function
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7964714B2 (en) * 2003-05-12 2011-06-21 Potomac Pharmaceuticals Inc. Gene expression suppression agents
US20050064547A1 (en) * 2003-09-24 2005-03-24 Brown Arthur M. Vectors and transfected cells
CA2543257C (en) 2003-10-24 2013-12-31 Gencia Corporation Methods and compositions for delivering polynucleotides
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
US8053232B2 (en) 2004-01-23 2011-11-08 Virxsys Corporation Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
JP2007523647A (ja) * 2004-02-05 2007-08-23 マサチューセッツ インスティテュート オブ テクノロジー 細胞ディスプレイライブラリー
EP2412816B1 (en) 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
US20080026410A1 (en) * 2004-12-02 2008-01-31 Antonia Vlahou Biomarkers for Bladder Cancer
WO2006081008A2 (en) * 2005-01-25 2006-08-03 Sky Genetics, Inc. Nucleic acids for apoptosis of cancer cells
US20060183893A1 (en) * 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells
US7790446B2 (en) * 2005-02-11 2010-09-07 Kosagen Cell Factory Oü Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
US8377653B2 (en) * 2005-02-11 2013-02-19 Icosagen Cell Factory Oü Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays
BRPI0608829A2 (pt) 2005-04-19 2011-03-15 Basf Plant Science Gmbh método para a expressão transgênica com especificidade intensificada em uma planta, uso de um construto de ácido nucleico quimérico, seqüência de ribonucleotìdeo quimérica, construto de expressão, vetor de expressão, organismo não-humano ou célula transformada, semente transformada, e, preparação farmacêutica
WO2006128085A2 (en) * 2005-05-27 2006-11-30 The Trustees Of Columbia University In The City Of New York Cadherin-11-mediated modulation of hair growth
WO2006128084A2 (en) * 2005-05-27 2006-11-30 The Trustees Of Columbia University In The City Of New York Trps1-mediated modulation of hair growth
CA2909775A1 (en) 2005-08-09 2007-03-29 Revivicor, Inc. Transgenic ungulates expressing ctla4-ig and uses thereof
CN101268194A (zh) 2005-09-20 2008-09-17 巴斯福植物科学有限公司 使用ta-siRNA调控基因表达的方法
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
CN101356270B (zh) * 2005-12-13 2014-02-12 国立大学法人京都大学 核重新编程因子
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US20080045471A1 (en) * 2006-03-27 2008-02-21 North Don A Nucleic Acids For Apoptosis Of Cancer Cells
US8252527B2 (en) * 2007-02-16 2012-08-28 The Research Foundation Of State University Of New York Method for identification of polynucleotides capable of cleaving target mRNA sequences
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2615172A1 (en) 2007-04-27 2013-07-17 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
AU2007352618B2 (en) 2007-05-02 2013-07-18 Boehringer Ingelheim Animal Health USA Inc. DNA plasmids having improved expression and stability
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) * 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
WO2009133971A1 (en) * 2008-05-02 2009-11-05 Kyoto University Method of nuclear reprogramming
CA2726862A1 (en) * 2008-06-30 2010-01-21 Atgcell Inc. Mammalian cell expression vectors and utilization
US8450473B2 (en) 2009-04-30 2013-05-28 The Research Foundation Of State University Of New York Compositions and methods for therapy of macular degeneration
DK2831276T3 (da) 2012-05-08 2016-08-01 Adaptive Biotechnologies Corp Sammensætninger og fremgangsmåde til at måle og kalibrere amplifikations-bias i multipleks-PCR-reaktioner
ES2704677T3 (es) * 2013-04-18 2019-03-19 Fond Telethon Suministro eficaz de genes grandes por vectores de AAV duales
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
GB201603372D0 (en) * 2016-02-26 2016-04-13 Ucl Business Plc Cell
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11572544B2 (en) 2017-06-14 2023-02-07 The Children's Medical Center Corporation Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
CN114269938A (zh) * 2019-06-21 2022-04-01 阿斯克肋匹奥生物制药公司 使用噬菌体复制起点生产载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5378618A (en) 1988-04-15 1995-01-03 E. I. Du Pont De Nemours And Company Vitro headful packaging system for cloning DNA fragments as large as 95kb
EP0511311A4 (en) 1990-01-19 1993-05-26 United States Government As Represented By The Secretary Of The Department Of Health And Human Services Novel retroviral vectors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000514473A5 (enExample)
JP2000501018A5 (enExample)
JP2000501324A5 (enExample)
JP2002514054A5 (enExample)
JP2001506735A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2001506386A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501229A5 (enExample)
JP2000500857A5 (enExample)
JP2000502316A5 (enExample)
JP2001501170A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)
JP2000500318A5 (enExample)